Philips Receives FDA Clearance for Image-Guided Prostate Cancer Solution
The newly cleared platform combines MR and ultrasound imaging to support real-time guidance for focal therapy and improve clinical accuracy.
The newly cleared platform combines MR and ultrasound imaging to support real-time guidance for focal therapy and improve clinical accuracy.
The CDC is investigating reports of an environmental bacterium linked to the use of ultrasound gel in percutaneous procedures across multiple states.
The AI algorithm delivered a 22-point improvement in anomaly detection in a multicenter study.Â
The newly cleared platform combines MR and ultrasound imaging to support real-time guidance for focal therapy and improve clinical accuracy.
Clarius Mobile Health has received U.S. FDA clearance for its OB AI tool, which uses deep learning to provide accurate fetal measurements.
Read MoreThe U.S. Army conducted an operational test of three portable ultrasound devices to evaluate their performance in battlefield conditions.
Read MoreNozomi Networks Labs discovered 11 vulnerabilities in GE HealthCare’s Vivid Ultrasound systems and software.
Read MoreRoyal Philips and Nicklaus Children’s Health System began a 10-year collaboration on pediatric care with new MR and ultrasound technology.
Read MoreGE HealthCare has launched the Voluson Signature 20 and 18 ultrasound systems, integrating AI, advanced tools, and ergonomic design.
Read MoreGE HealthCare launched Caption AI software for rapid cardiac assessments at the point of care on Vscan Air SL.Â
Read MoreThe Sonosite Voice Assist application is a voice command feature that can control Sonosite PX and Sonosite LX systems hands free.